Publications by authors named "M Bombardieri"

The pathogenesis of Sjögren's disease (SjD) is still elusive; however, the disease is widely recognised as a multistep disorder triggered by the interplay of environmental, hormonal and genetic factors. Innate immune system plays a crucial role in the initiation of the inflammatory process, but the amplification and the perpetuation of the autoimmune process require a continual interaction between the innate and adaptive immune systems. Several important contributions elucidating SjD pathogenesis have been recently published due to emerging technologies.

View Article and Find Full Text PDF

Inflammatory rheumatic diseases are different pathologic conditions associated with a deregulated immune response, codified along a spectrum of disorders, with autoinflammatory and autoimmune diseases as two-end phenotypes of this continuum. Despite pathogenic differences, inflammatory rheumatic diseases are commonly managed with a limited number of immunosuppressive drugs, sometimes with partial evidence or transferring physicians' knowledge in different patients. In addition, several randomized clinical trials, enrolling these patients, did not meet the primary pre-established outcomes and these findings could be linked to the underlying molecular diversities along the spectrum of inflammatory rheumatic disorders.

View Article and Find Full Text PDF

Aquaporins (AQPs) are a family of water permeable channels expressed on the plasma membrane with AQP5 being the major channel expressed in several human tissues including salivary and lacrimal glands. Anti-AQP5 autoantibodies have been observed in patients with Sjögren's syndrome who are characterised by dryness of both salivary and lacrimal glands, and they have been implicated in the underlying mechanisms of glandular dysfunction. AQP5 is formed by six transmembrane helices linked with three extracellular and two intracellular loops.

View Article and Find Full Text PDF
Article Synopsis
  • Ectopic lymphoid structures in rheumatoid arthritis (RA) joints contribute to autoimmunity by sustaining responses against specific autoantigens, particularly targeting fibroblast-like synoviocytes (FLSs) with newly identified monoclonal antibodies.
  • Among these antibodies, some specifically recognize HSP60 and show limited cross-reactivity with other proteins, but not with citrullinated fibrinogen.
  • The study highlights that HSP60 antibodies are more prevalent in RA patients compared to those with osteoarthritis, suggesting the possibility of using these autoantibodies to improve patient classification and predict responses to therapies like B cell depletion.
View Article and Find Full Text PDF